MRNA logo

Moderna (MRNA) Non Current Assets

Annual Non Current Assets

$8.10 B
-$4.33 B-34.81%

31 December 2023

MRNA Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$6.14 B
+$118.00 M+1.96%

30 September 2024

MRNA Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MRNA Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-34.8%-29.1%
3 y3 years+679.7%-18.1%
5 y5 years+1929.6%+1136.2%

MRNA Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-34.8%+679.7%-50.8%+2.0%
5 y5 years-34.8%+1929.6%-50.8%+1232.3%
alltimeall time-34.8%>+9999.0%-50.8%

Moderna Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$6.14 B(+2.0%)
June 2024
-
$6.02 B(-15.6%)
Mar 2024
-
$7.13 B(-12.0%)
Dec 2023
$10.32 B(-23.1%)
$8.10 B(-6.4%)
Sept 2023
-
$8.65 B(-23.3%)
June 2023
-
$11.29 B(-6.0%)
Mar 2023
-
$12.00 B(-3.4%)
Dec 2022
$13.43 B(-16.4%)
$12.43 B(+5.7%)
Sept 2022
-
$11.76 B(-5.8%)
June 2022
-
$12.48 B(+10.8%)
Mar 2022
-
$11.26 B(+30.9%)
Dec 2021
$16.07 B(+155.2%)
$8.60 B(+14.7%)
Sept 2021
-
$7.50 B(+44.6%)
June 2021
-
$5.18 B(+423.1%)
Mar 2021
-
$991.00 M(-4.6%)
Dec 2020
$6.30 B(+457.9%)
$1.04 B(-3.2%)
Sept 2020
-
$1.07 B(+55.8%)
June 2020
-
$689.26 M(-15.7%)
Mar 2020
-
$817.61 M(+77.5%)
Dec 2019
$1.13 B(-27.8%)
$460.62 M(-7.2%)
Sept 2019
-
$496.43 M(-15.6%)
June 2019
-
$587.86 M(-11.7%)
Mar 2019
-
$665.38 M(+66.7%)
Dec 2018
$1.56 B(+99.6%)
$399.14 M(+7.5%)
Sept 2018
-
$371.21 M(+23.2%)
Dec 2017
$783.22 M(-28.0%)
$301.27 M(+4773.2%)
Sept 2017
-
$6.18 M(-0.8%)
June 2017
-
$6.23 M(+9.0%)
Mar 2017
-
$5.72 M(-2.6%)
Dec 2016
$1.09 B(>+9900.0%)
-
Dec 2016
-
$5.87 M(-12.4%)
Sept 2016
-
$6.70 M(0.0%)
June 2016
-
$6.70 M(-0.7%)
Mar 2016
-
$6.75 M(0.0%)
Dec 2015
$850.00 K(-66.2%)
$6.75 M(0.0%)
Sept 2015
-
$6.75 M(0.0%)
June 2015
-
$6.75 M(0.0%)
Mar 2015
-
$6.75 M(+0.7%)
Dec 2014
$2.52 M(+141.5%)
$6.70 M(0.0%)
Sept 2014
-
$6.70 M(0.0%)
June 2014
-
$6.70 M(0.0%)
Mar 2014
-
$6.70 M(0.0%)
Dec 2013
$1.04 M(+42.3%)
$6.70 M(0.0%)
Sept 2013
-
$6.70 M(0.0%)
June 2013
-
$6.70 M(0.0%)
Mar 2013
-
$6.70 M(-0.3%)
Dec 2012
$732.00 K(-71.6%)
$6.72 M(+0.3%)
Sept 2012
-
$6.70 M(-22.1%)
June 2012
-
$8.60 M(-1.9%)
Mar 2012
-
$8.77 M(-4.4%)
Dec 2011
$2.58 M(-13.0%)
$9.17 M(-64.0%)
Sept 2011
-
$25.47 M(-1.2%)
June 2011
-
$25.77 M(-1.3%)
Mar 2011
-
$26.12 M(-1.4%)
Dec 2010
$2.96 M(+11.4%)
$26.48 M(+479.2%)
Sept 2010
-
$4.57 M(+17.0%)
June 2010
-
$3.91 M(-8.2%)
Mar 2010
-
$4.26 M(-6.9%)
Dec 2009
$2.66 M(-46.4%)
$4.57 M(-10.7%)
Sept 2009
-
$5.12 M(-12.4%)
June 2009
-
$5.84 M(-10.5%)
Mar 2009
-
$6.53 M(-20.2%)
DateAnnualQuarterly
Dec 2008
$4.96 M(-88.9%)
$8.18 M(-7.4%)
Sept 2008
-
$8.84 M(-30.1%)
June 2008
-
$12.63 M(-20.2%)
Mar 2008
-
$15.83 M(-6.6%)
Dec 2007
$44.68 M(-22.4%)
$16.94 M(-13.8%)
Sept 2007
-
$19.65 M(-1.1%)
June 2007
-
$19.87 M(+16.8%)
Mar 2007
-
$17.00 M(+4.5%)
Dec 2006
$57.56 M(-10.6%)
$16.27 M(+9.9%)
Sept 2006
-
$14.81 M(+19.5%)
June 2006
-
$12.40 M(+32.2%)
Mar 2006
-
$9.38 M(+9.4%)
Dec 2005
$64.38 M(-14.4%)
$8.58 M(+2.3%)
Sept 2005
-
$8.39 M(+16.3%)
June 2005
-
$7.21 M(-10.3%)
Mar 2005
-
$8.04 M(+44.4%)
Dec 2004
$75.20 M(+191.1%)
$5.57 M(+2.5%)
Sept 2004
-
$5.44 M(+6.7%)
June 2004
-
$5.10 M(-9.4%)
Mar 2004
-
$5.63 M(+6.1%)
Dec 2003
$25.83 M(+148.3%)
$5.30 M(+10.6%)
Sept 2003
-
$4.80 M(-14.0%)
June 2003
-
$5.58 M(-56.9%)
Mar 2003
-
$12.93 M(+2.3%)
Dec 2002
$10.40 M(-15.5%)
$12.64 M(-7.8%)
Sept 2002
-
$13.72 M(+213.4%)
June 2002
-
$4.38 M(+37.9%)
Mar 2002
-
$3.17 M(+1.7%)
Dec 2001
$12.32 M(+56.0%)
$3.12 M(-4.0%)
Sept 2001
-
$3.25 M(-5.2%)
June 2001
-
$3.43 M(-5.4%)
Mar 2001
-
$3.63 M(-3.7%)
Dec 2000
$7.89 M(-52.2%)
$3.77 M(-3.0%)
Sept 2000
-
$3.88 M(+1.1%)
June 2000
-
$3.84 M(-1.7%)
Mar 2000
-
$3.91 M(+5.6%)
Dec 1999
$16.50 M(-37.7%)
$3.70 M(+42.3%)
Sept 1999
-
$2.60 M(+62.5%)
June 1999
-
$1.60 M(+33.3%)
Mar 1999
-
$1.20 M(+20.0%)
Dec 1998
$26.50 M(-0.4%)
$1.00 M(-9.1%)
Sept 1998
-
$1.10 M(+22.2%)
June 1998
-
$900.00 K(+12.5%)
Mar 1998
-
$800.00 K(0.0%)
Dec 1997
$26.60 M(+114.5%)
$800.00 K(0.0%)
Sept 1997
-
$800.00 K(0.0%)
June 1997
-
$800.00 K(+33.3%)
Mar 1997
-
$600.00 K(+100.0%)
Dec 1996
$12.40 M(+36.3%)
-
Sept 1996
-
$300.00 K(0.0%)
June 1996
$9.10 M(0.0%)
$300.00 K(0.0%)
Mar 1996
-
$300.00 K(+50.0%)
Dec 1995
-
$200.00 K(0.0%)
Sept 1995
-
$200.00 K(-33.3%)
June 1995
$9.10 M(+54.2%)
$300.00 K(+200.0%)
Mar 1995
-
$100.00 K(>+9900.0%)
Dec 1994
-
$0.00(-100.0%)
Sept 1994
-
$100.00 K(0.0%)
June 1994
$5.90 M
$100.00 K(>+9900.0%)
Mar 1994
-
$0.00(0.0%)
Dec 1993
-
$0.00(-100.0%)
Sept 1993
-
$200.00 K

FAQ

  • What is Moderna annual long term assets?
  • What is the all time high annual non current assets for Moderna?
  • What is Moderna annual non current assets year-on-year change?
  • What is Moderna quarterly long term assets?
  • What is the all time high quarterly non current assets for Moderna?
  • What is Moderna quarterly non current assets year-on-year change?

What is Moderna annual long term assets?

The current annual non current assets of MRNA is $8.10 B

What is the all time high annual non current assets for Moderna?

Moderna all-time high annual long term assets is $12.43 B

What is Moderna annual non current assets year-on-year change?

Over the past year, MRNA annual long term assets has changed by -$4.33 B (-34.81%)

What is Moderna quarterly long term assets?

The current quarterly non current assets of MRNA is $6.14 B

What is the all time high quarterly non current assets for Moderna?

Moderna all-time high quarterly long term assets is $12.48 B

What is Moderna quarterly non current assets year-on-year change?

Over the past year, MRNA quarterly long term assets has changed by -$2.51 B (-29.06%)